Sage Therapeutics (SAGE) News Today $8.68 0.00 (0.00%) As of 07/31/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SAGE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Why Are Supernus Pharmaceuticals (SUPN) Shares Soaring TodayAugust 6, 2025 | finance.yahoo.comGSA Capital Partners LLP Increases Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE)August 5, 2025 | marketbeat.comFederated Hermes Inc. Increases Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE)August 3, 2025 | marketbeat.comAnalysts Set Sage Therapeutics, Inc. (NASDAQ:SAGE) Price Target at $8.02August 3, 2025 | americanbankingnews.comWall Street Zen Upgrades Sage Therapeutics (NASDAQ:SAGE) to HoldAugust 2, 2025 | marketbeat.comSupernus strengthens neuropsychiatric portfolio with Sage TherapeuticsAugust 1, 2025 | finance.yahoo.comSage Therapeutics, Inc. (NASDAQ:SAGE) Receives Average Rating of "Reduce" from BrokeragesJuly 31, 2025 | marketbeat.comSage Therapeutics Announces Second Quarter 2025 Financial ResultsJuly 31, 2025 | finance.yahoo.comSage Therapeutics (NASDAQ:SAGE) Sees Strong Trading Volume - Time to Buy?July 30, 2025 | marketbeat.comMonaco Asset Management SAM Takes $3.51 Million Position in Sage Therapeutics, Inc. (NASDAQ:SAGE)July 30, 2025 | marketbeat.comCerity Partners LLC Purchases New Stake in Sage Therapeutics, Inc. (NASDAQ:SAGE)July 27, 2025 | marketbeat.comBML Capital Management LLC Buys New Shares in Sage Therapeutics, Inc. (NASDAQ:SAGE)July 26, 2025 | marketbeat.comCwm LLC Acquires 58,410 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE)July 25, 2025 | marketbeat.comSage Therapeutics (SAGE) Expected to Announce Earnings on WednesdayJuly 23, 2025 | marketbeat.comSage Therapeutics (NASDAQ:SAGE) Sees Large Volume Increase - What's Next?July 22, 2025 | marketbeat.comSage Therapeutics (NASDAQ:SAGE) Shares Pass Above Fifty Day Moving Average - Should You Sell?July 16, 2025 | marketbeat.comSAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGEJuly 14, 2025 | businesswire.comBeyond The Numbers: 6 Analysts Discuss Sage Therapeutics StockJuly 9, 2025 | nasdaq.comScotiabank Downgrades Sage Therapeutics (SAGE)July 9, 2025 | msn.comScotiabank Reiterates "Sector Perform" Rating for Sage Therapeutics (NASDAQ:SAGE)July 8, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Takes $347,000 Position in Sage Therapeutics, Inc. (NASDAQ:SAGE)July 8, 2025 | marketbeat.comSage Therapeutics (NASDAQ:SAGE) Share Price Passes Above Two Hundred Day Moving Average - Here's WhyJuly 4, 2025 | marketbeat.comSage Therapeutics (NASDAQ:SAGE) Shares Pass Above 50 Day Moving Average - Here's WhyJuly 4, 2025 | marketbeat.comM&A ramped up in June, with blueBird, Sage and Snyk tie-upsJuly 2, 2025 | bizjournals.comBoston-area pharma company to lay off entire 300-person staff after saleJuly 1, 2025 | msn.com$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Sage Therapeutics, Inc. (NASDAQ: SAGE)July 1, 2025 | globenewswire.comThis common kitchen herb ingredient could help target or slow Alzheimer’sJune 29, 2025 | msn.comSage Therapeutics Stock: JPMorgan Sees 8% Downside After Supernus Buyout TermsJune 23, 2025 | msn.comPhathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate SecretaryJune 23, 2025 | globenewswire.comSage Therapeutics price target lowered to $8.50 from $11 at JPMorganJune 22, 2025 | msn.comSage Therapeutics (NASDAQ:SAGE) Given New $9.00 Price Target at Robert W. BairdJune 20, 2025 | marketbeat.comSAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGEJune 18, 2025 | businesswire.comSage Therapeutics (NASDAQ:SAGE) Earns Neutral Rating from Piper SandlerJune 17, 2025 | marketbeat.comSage Therapeutics (NASDAQ:SAGE) Price Target Raised to $9.00June 17, 2025 | marketbeat.comHC Wainwright Reaffirms "Neutral" Rating for Sage Therapeutics (NASDAQ:SAGE)June 17, 2025 | marketbeat.comSage Therapeutics (NASDAQ:SAGE) Given New $8.50 Price Target at Canaccord Genuity GroupJune 17, 2025 | marketbeat.comSupernus makes depression drug play with $795m Sage buyoutJune 16, 2025 | msn.comSage Therapeutics Stock Soars 36% After Sale to Supernus Pharmaceuticals. What We Know.June 16, 2025 | msn.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.June 16, 2025 | prnewswire.comSage Therapeutics (NASDAQ:SAGE) Shares Gap Up - Should You Buy?June 16, 2025 | marketbeat.comSAGE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Sage Therapeutics, Inc. Is Fair to ShareholdersJune 16, 2025 | businesswire.comShareholder Alert: The Ademi Firm Investigates Whether Sage Therapeutics, Inc. ...June 16, 2025 | gurufocus.comSage Therapeutics Stock Soars 35% After Sale to Supernus. What We Know.June 16, 2025 | barrons.comShareholder Alert: The Ademi Firm Investigates Whether Sage Therapeutics, Inc. Is Obtaining a Fair Price for Its Public ShareholdersJune 16, 2025 | businesswire.comSupernus Pharma to acquire Sage Therapeutics in up to $795 million dealJune 16, 2025 | reuters.comSage Therapeutics, Inc. (NASDAQ:SAGE) Given Consensus Rating of "Hold" by AnalystsJune 11, 2025 | marketbeat.comSquarepoint Ops LLC Has $126,000 Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE)June 10, 2025 | marketbeat.comWall Street Zen Downgrades Sage Therapeutics (NASDAQ:SAGE) to SellJune 7, 2025 | marketbeat.comMajor Depressive Disorder Pipeline Appears Robust With 75+ Key Companies Actively Working in the Therapeutics Segment | DelveInsightJune 5, 2025 | theglobeandmail.comBank of America Corp DE Sells 355,277 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE)June 4, 2025 | marketbeat.com Get Sage Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SAGE and its competitors with MarketBeat's FREE daily newsletter. Email Address SAGE Media Mentions By Week SAGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SAGE News Sentiment▼1.270.75▲Average Medical News Sentiment SAGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SAGE Articles This Week▼26▲SAGE Articles Average Week Get Sage Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SAGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Bausch Health Cos News Today Ocular Therapeutix News Today Agios Pharmaceuticals News Today Denali Therapeutics News Today IDEAYA Biosciences News Today Tarsus Pharmaceuticals News Today Disc Medicine News Today Harmony Biosciences News Today Mesoblast News Today CG Oncology News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SAGE) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sage Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sage Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access